Better Therapeutics, Inc. - Common Stock (NQ:BTTX)

N/A UNCHANGED

Last Price Updated: 4:00 PM EDT, Mar 15, 2024 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Better Therapeutics, Inc. - Common Stock

< Previous 1 2 3 4 5 6 7 8 Next >

Dow Jumps Over 100 Points; US Small Business Optimism Index Tops Estimates ↗

July 11, 2023

U.S. stocks traded higher this morning, with the Dow Jones gaining over 100 points on Tuesday. Following the market opening Tuesday, the Dow traded up 0.40% to 34,080.13 while the NASDAQ rose 0.23% to...

Via Benzinga

Why Are Better Therapeutics Shares Gaining Today? ↗

July 11, 2023

Better Therapeutics Inc (NASDAQ: BTTX) shares are trading higher after the FDA approved the company's AspyreRx (formerly BT-001), a prescription-only digital treatment to provide cognitive behavioral...

Via Benzinga

Why Is Iovance Biotherapeutics (IOVA) Stock Down 10% Today? ↗

July 11, 2023

Iovance Biotherapeutics (IOVA) stock is sliding lower on Tuesday after the company announced details of a public share offering.

Via InvestorPlace

Why Is EzFill (EZFL) Stock Down 5% Today? ↗

July 11, 2023

EzFill (EZFL) stock is taking a beating on Tuesday despite the company releasing positive data from the second quarter of 2023.

Via InvestorPlace

12 Health Care Stocks Moving In Tuesday's Pre-Market Session ↗

July 11, 2023

Via Benzinga

Better Therapeutics: Q1 Earnings Insights ↗

May 11, 2023

Via Benzinga

Better Therapeutics's Earnings: A Preview ↗

May 10, 2023

Via Benzinga

A Preview Of Better Therapeutics's Earnings ↗

March 29, 2023

Via Benzinga

Why Is Better Therapeutics (BTTX) Stock Up 39% Today? ↗

July 11, 2023

Better Therapeutics (BTTX) stock is taking off on Tuesday as investors react to approval from the FDA for a Type 2 diabetes treatment.

Via InvestorPlace

Why Better Therapeutics Are Trading Higher By 51%; Here Are 20 Stocks Moving Premarket ↗

July 11, 2023

Gainers CytoMed Therapeutics Limited (NASDAQ: GDTC) shares surged 109.2% to $7.30 in pre-market trading after gaining 9% on Monday.

Via Benzinga

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Tuesday ↗

July 11, 2023

It's time for another breakdown of the biggest pre-market stock movers as we check out all of the shares rising and falling on Tuesday!

Via InvestorPlace

Better Therapeutics Receives FDA Authorization for AspyreRx™ to Treat Adults with Type 2 Diabetes

July 10, 2023

From Better Therapeutics, Inc.

Via Business Wire

Better Therapeutics Announces Upcoming Poster Presentation at EASL Congress 2023 in Vienna, Austria

June 16, 2023

From Better Therapeutics, Inc.

Via Business Wire

Better Therapeutics Reports First Quarter 2023 Financial Results and Provides Business Updates

May 11, 2023

From Better Therapeutics, Inc.

Via Business Wire

12 Health Care Stocks Moving In Monday's Intraday Session ↗

May 08, 2023

Via Benzinga

Better Therapeutics to Release First Quarter 2023 Financial Results and Provide Business Update on May 11, 2023

May 04, 2023

From Better Therapeutics, Inc.

Via Business Wire

Why Tupperware Brands Shares Are Trading Lower By Over 40%? Here Are Other Stocks Moving In Monday's Mid-Day Session ↗

April 10, 2023

Gainers PLx Pharma Inc. (NASDAQ: PLXP) gained 128.2% to $0.2399 after dropping over 13% on Thursday.

Via Benzinga

12 Health Care Stocks Moving In Friday's After-Market Session ↗

April 07, 2023

Via Benzinga

12 Health Care Stocks Moving In Friday's Intraday Session ↗

April 07, 2023

Via Benzinga

12 Health Care Stocks Moving In Thursday's Intraday Session ↗

April 06, 2023

Via Benzinga

Better Therapeutics Announces $6.5MM Private Placement

April 06, 2023

From Better Therapeutics, Inc.

Via Business Wire

Why Bed Bath & Beyond Shares Are Trading Lower By 15%? Here Are Other Stocks Moving In Thursday's Mid-Day Session ↗

March 30, 2023

Gainers SCYNEXIS, Inc. (NASDAQ: SCYX) shares climbed 68% to $2.8184 after the company announced an exclusive license agreement with GSK for Brexafemme, in which the company will receive an upfront...

Via Benzinga

Better Therapeutics Reports Fourth Quarter and Full Year 2022 Financial Results and Provides Business Updates

March 30, 2023

From Better Therapeutics, Inc.

Via Business Wire

Better Therapeutics to Release Fourth Quarter and Full Year 2022 Financial Results and Provide Business Update on March 30, 2023

March 23, 2023

From Better Therapeutics, Inc.

Via Business Wire

Better Therapeutics to Participate in Two Upcoming Investor Conferences

February 09, 2023

From Better Therapeutics, Inc.

Via Business Wire

Better Therapeutics Posts Encouraging Data Establishing Proof-Of-Concept For Prescription Digital Therapy Platform ↗

December 08, 2022

Via Benzinga

Better Therapeutics Completes Exploratory Trial for Fatty Liver Disease and Announces Positive Topline Results

December 08, 2022

From Better Therapeutics, Inc.

Via Business Wire

Better Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

December 02, 2022

From Better Therapeutics, Inc.

Via Business Wire

Better Therapeutics to Participate in BTIG Digital Health Forum

November 15, 2022

From Better Therapeutics, Inc.

Via Business Wire

PDS Biotechnology To Rally Around 129%? Here Are 5 Other Price Target Changes For Tuesday ↗

November 15, 2022

Via Benzinga

< Previous 1 2 3 4 5 6 7 8 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io. Quotes delayed at least 20 minutes. Market data may be delayed. Research information, not personalized advice.